GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LabGenomics Co Ltd (XKRX:084650) » Definitions » Capital Expenditure

LabGenomics Co (XKRX:084650) Capital Expenditure : ₩-3,270.40 Mil (TTM As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is LabGenomics Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

LabGenomics Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ₩-129 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-3,270.40 Mil.

LabGenomics Co Capital Expenditure Historical Data

The historical data trend for LabGenomics Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LabGenomics Co Capital Expenditure Chart

LabGenomics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,515.02 -13,814.52 -38,329.81 -5,196.31 -4,547.44

LabGenomics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,406.32 -1,434.29 -1,467.98 -238.85 -129.27

LabGenomics Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-3,270.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LabGenomics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LabGenomics Co Ltd (XKRX:084650) » Definitions » Capital Expenditure
Comparable Companies
XKRX:950130 XKRX:038290 XKRX:144510 XKRX:461030 XKRX:051980 XKRX:180400 XKRX:384470 XKRX:217330 XKRX:376930 XKRX:347740 TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT
Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, 6F-B, Bundang-gu, Korea Bio Park Building, Gyeonggi-do, Seongnam, KOR, 463-400
Website
http://www.labgenomics.co.kr
LabGenomics Co Ltd is a healthcare company. The Company operates in three business divisions namely NGS, Diagnostic service, IVD products. NGS offers mom guard, cancer panel, Predisposition panel and PGS; Diagnostic service provides esoteric tests such as cancer genetics, genetic disorder. Whereas IVD products include DNA chips, PCR kit among others.

LabGenomics Co Headlines

No Headlines